A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.
Clinical trial NCT02072824 · COMPLETED
Trial details
- NCT number
- NCT02072824
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-16
- Primary completion
- 2018-03-13
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.